VEGFA and cancer: Nevertheless, several angiogenic factors such as VEGF-A, VEGF-B, angiopoietin-1, osteopontin, fibroblast growth factor, MMPs, and others currently serve as targets in cancer treatment with FDA-approved inhibitors which all are being used in conjunction with chemotherapy [1,3].